Clinical Trial Detail

NCT ID NCT03770689
Title Phase Ib/II Study of M3814 in Combination With Capecitabine and Radiotherapy in Rectal Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors EMD Serono Research & Development Institute, Inc.
Indications

rectum cancer

Therapies

Capecitabine

Capecitabine + MSC2490484A

Age Groups: adult senior

No variant requirements are available.